mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.3 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |